Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,590 | -9,948 | -4,992 | -23,516 | -17,867 |
| Depreciation Amortization | 406 | 277 | 141 | 546 | 412 |
| Accounts payable and accrued liabilities | 839 | 311 | 110 | -183 | 484 |
| Other Working Capital | 424 | 184 | 230 | -616 | 85 |
| Other Operating Activity | 2,188 | 1,719 | 961 | 4,911 | 3,001 |
| Operating Cash Flow | $-11,733 | $-7,457 | $-3,550 | $-18,858 | $-13,885 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -24 | -10 | -33 | -29 |
| Purchase Of Investment | -33,420 | -25,068 | -15,135 | -56,520 | -24,276 |
| Sale Of Investment | 45,844 | 31,263 | 17,343 | 48,685 | 38,581 |
| Investing Cash Flow | $12,391 | $6,171 | $2,198 | $-7,868 | $14,276 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,637 | 46 | 46 | 25,791 | N/A |
| Financing Cash Flow | $13,637 | $46 | $46 | $25,791 | $N/A |
| Beginning Cash Position | 3,620 | 3,620 | 3,620 | 4,555 | 4,555 |
| End Cash Position | 17,915 | 2,380 | 2,314 | 3,620 | 4,946 |
| Net Cash Flow | $14,295 | $-1,240 | $-1,306 | $-935 | $391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,733 | -7,457 | -3,550 | -18,858 | -13,885 |
| Capital Expenditure | -33 | -24 | -10 | -33 | -29 |
| Free Cash Flow | -11,766 | -7,481 | -3,560 | -18,891 | -13,914 |